Arkion Life Sciences, LLC
Records under this name other than the patents Arkion Life Sciences, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Arkion Life Sciences, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,450,364 | Hyperimmunized Egg Product for Treatment of Necrotic Enteritis in Poultry Formerly held In force · High confidence | In force | High confidence | |
| US 11,230,590 | Hyperimmunized Egg Product for Treatment of Necrotic Enteritis in Poultry Formerly held In force · High confidence | In force | High confidence | |
| US 8,124,381 | Process and materials for production of glucosamine and N-acetylglucosamine Term ended Term ended Jul 7, 2026 · From the USPTO record | Term ended | Term ended Jul 7, 2026 | From the USPTO record |
| US 7,910,560 | Method for increasing breast meat yield in poultry Term ended Term ended Jan 28, 2026 · From the USPTO record | Term ended | Term ended Jan 28, 2026 | From the USPTO record |
| US 7,332,304 | Process and materials for production of glucosamine and N-acetylglucosamine Term ended Term ended Oct 5, 2024 · From the USPTO record | Term ended | Term ended Oct 5, 2024 | From the USPTO record |
| US 7,083,809 | Purified cytokine inhibitory factor Term ended Term ended Aug 8, 2024 · From the USPTO record | Term ended | Term ended Aug 8, 2024 | From the USPTO record |
| US 9,089,514 | Composition and method for inhibiting biogenic sulfide generation Lapsed on the fee record Ended Jul 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 28, 2023 | From the USPTO record |
| US 6,743,440 | Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals Term ended Term ended Aug 8, 2021 · From the USPTO record | Term ended | Term ended Aug 8, 2021 | From the USPTO record |
| US 6,706,267 | Glucosamine and egg for reducing inflammation Term ended Term ended Mar 21, 2021 · From the USPTO record | Term ended | Term ended Mar 21, 2021 | From the USPTO record |
| US 6,420,337 | Highly purified cytokine activating factor and methods of use Term ended Term ended Jul 20, 2020 · From the USPTO record | Term ended | Term ended Jul 20, 2020 | From the USPTO record |